A Large-Scale Genome-Wide Gene-Sleep Interaction Study in 732,564 Participants Identifies Lipid Loci Explaining Sleep-Associated Lipid Disturbances

Raymond Noordam,Wenyi Wang,Pavithra Nagarajan,Heming Wang,Michael R Brown,Amy R Bentley,Qin Hui,Aldi T Kraja,John L Morrison,Jeffrey R O'Connel,Songmi Lee,Karen Schwander,Traci M Bartz,Lisa de las Fuentes,Mary F Feitosa,Xiuqing Guo,Xu Hanfei,Sarah E Harris,Zhijie Huang,Mart Kals,Christophe Lefevre,Massimo Mangino,Yuri Milaneschi,Peter van der Most,Natasha L Pacheco,Nicholette D Palmer,Varun Rao,Rainer Rauramaa,Quan Sun,Yasuharu Tabara,Dina Vojinovic,Yujie Wang,Stefan Weiss,Qian Yang,Wei Zhao,Wanyng Zhu,Md Abu Yusuf Ansari,Hugues Aschard,Pramod Anugu,Themistocles L Assimes,John Attia,Laura D Baker,Christie Ballantyne,Lydia Bazzano,Eric Boerwinkle,Brain Cade,Hung-hsin Chen,Wei Chen,Yii-Der Ida Chen,Zekai Chen,Kelly Cho,Illeana De Anda-Duran,Latchezar Dimitrov,Anh Do,Todd Edwards,Tariq Faquih,Aroon Hingorani,Susan P Fisher-Hoch,J. Michael Gaziano,Sina A Gharib,Ayush Giri,Mohsen Ghanbari,Hans Jorgen Grabe,Mariaelisa Graff,C Charles Gu,Jiang He,Sami Heikkinen,James Hixson,Yuk-Lam Ho,Michelle M Hood,Serena C Houghton,Carrie A Karvonen-Gutierrez,Takahisa Kawaguchi,Tuomas O Kilpelainen,Pirjo Komulainen,Henry J Lin,Gregorio V Linchangzo Jr.,Annemari I Luik,Jintao Ma,James B Meigs,Joseph B McCormick,Christina Menni,Ilja M Nolte,Jimm M Norris,Lauren E Petty,Hannah G Polikowsky,Laura M Raffield,Stephen S Rich,Renata L Riha,Thomas C Russ,Edward A Ruiz-Narvaez,Colleen M Sitlani,Jennifer A Smith,Harold Snieder,Tamar Sofer,Botong Shen,Jingxian Tang,Kent D Taylor,Maris Tader-Laving,Rima Triatin,Michael Y Tsai,Henry Volzke,Kenneth E Westerman,Rui Xia,Jie Yao,Kristin L Young,Ruiyuan Zhang,Alan B Zonderman,Xiaofeng Zhu,Jennifer E Below,Simon R Cox,Michelle Evans,Myriam Fornage,Ervin R Fox,Nora Franceschini,Sioban D Harlow,Elizabeth Holliday,M Arfan Ikram,Tanika Kelly,Timo A Lakka,Deborah A Lawlor,Changwei Li,Ching-Ti Liu,Reedik Magi,Alisa K Manning,Famihiko Matsuda,Alanna C Morrison,Matthias Nauck,Kari E North,Brenda WJH Penninx,Michael A Province,Bruce M Psaty,Jerome I Rotter,Tim D Spector,Lynne E Wagenknecht,Ko Willems van Dijk,Lifelines Cohort Study,Million Veteran Program,Cashell E Jaquish,Peter WF Wilson,Patricia A Peyser,Patricia B Munroe,Paul S de Vries,W James Gauderman,Yan V Sun,Han Chen,Clint L Miller,Thomas W Winkler,Dabeeru C Rao,Susan Redline,Diana van Heemst

DOI: https://doi.org/10.1101/2024.09.02.24312466

2024-09-04

Abstract:We performed large-scale genome-wide gene-sleep interaction analyses of lipid levels to identify novel genetic variants underpinning the biomolecular pathways of sleep-associated lipid disturbances and to suggest possible druggable targets. We collected data from 55 cohorts with a combined sample size of 732,564 participants (87% European ancestry) with data on lipid traits (high-density lipoprotein [HDL-c] and low-density lipoprotein [LDL-c] cholesterol and triglycerides [TG]). Short (STST) and long (LTST) total sleep time were defined by the extreme 20% of the age- and sex-standardized values within each cohort. Based on cohort-level summary statistics data, we performed meta-analyses for the one-degree of freedom tests of interaction and two-degree of freedom joint tests of the main and interaction effect. In the cross-population meta-analyses, the one-degree of freedom variant-sleep interaction test identified 10 loci (Pint<5.0e-9) not previously observed for lipids. Of interest, the ASPH locus (TG, LTST) is a target for aspartic and succinic acid metabolism previously shown to improve sleep and cardiovascular risk. The two-degree of freedom analyses identified an additional 7 loci that showed evidence for variant-sleep interaction (Pjoint<5.0e-9 in combination with Pint<6.6e-6). Of these, the SLC8A1 locus (TG, STST) has been considered a potential treatment target for reduction of ischemic damage after acute myocardial infarction. Collectively, the 17 (9 with STST; 8 with LTST) loci identified in this large-scale initiative provides evidence into the biomolecular mechanisms underpinning sleep-duration-associated changes in lipid levels. The identified druggable targets may contribute to the development of novel therapies for dyslipidemia in people with sleep disturbances.